OncoCyte Corp (STU:7OC0)
€ 3.34 0 (0%) Market Cap: 32.55 Mil Enterprise Value: 30.49 Mil PE Ratio: 0 PB Ratio: 1.89 GF Score: 32/100

Q3 2023 OncoCyte Corp Earnings Call Transcript

Nov 09, 2023 / 01:00PM GMT
Release Date Price: €3.34
Operator

Thank you for standing by. My name is Tamika, and I will be your conference operator today. At this time, I would like to welcome everyone to the Oncocyte Third Quarter 2023 Earnings Conference Call. (Operator Instructions)

I will now hand today's call over to Stephanie Prince of PCG Advisory. Please go ahead.

Stephanie Prince
ProActive Capital Group, LLC - MD

Thank you, Tamika, and thank you to everyone joining us for today's conference call to discuss Oncocyte's third quarter 2023 financial results and recent operating highlights. If you have not seen today's financial results press release, please visit the company's website on the Investors page.

Before turning the call over to Josh Riggs, Oncocyte's President and CEO, I would like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. Any statements that are not historical facts are forward-looking statements. We encourage you to review the company's SEC filings, including, without limitation, the company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot